Search results
Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
Zacks via Yahoo Finance· 6 months agoRoche's (RHHBY) phase III study evaluating inavolisib in combination with advanced hormone...
Sanofi (SNY) Ends Development of Breast Cancer Drug, Stock Down
Zacks via Yahoo Finance· 2 years agoShares of Sanofi SNY were down 5.8% in the pre-market trading session on Aug 17, after management...
Novartis drug cuts recurrence risk by 25% in early-stage breast cancer
Reuters via Yahoo Finance· 1 year agoNovartis breast cancer drug Kisqali cut the risk of recurrence by more than 25% in a pivotal trial...
Novartis Announces Positive Data on Breast Cancer Drug Kisqali
Zacks via Yahoo Finance· 1 year agoNovartis NVS announced positive data on the breast cancer drug Kisqali (ribociclib) from the...
What are the latest developments in breast cancer treatment? Central Mass. experts explain
Worcester Telegram & Gazette via Yahoo News· 8 months agoWORCESTER — October is Breast Cancer Awareness Month, and the rate of breast cancer incidence for...
What Is HER2-Negative Breast Cancer?
Verywell Health via Yahoo News· 2 years agoMedically reviewed by Doru Paul, MDMedically reviewed by Doru Paul, MD HER2-negative breast cancer is a type of breast cancer that accounts for about 78%...
How HER2-Negative Breast Cancer Is Treated
Verywell Health via Yahoo News· 2 years agoMedically reviewed by Doru Paul, MDMedically reviewed by Doru Paul, MD Treating HER2-negative breast cancer and other types of breast cancer may require...
Olema (OLMA) Up on FDA Fast Track Tag for Breast Cancer Drug
Zacks via Yahoo Finance· 2 years agoThe FDA bestows a Fast Track designation to Olema's (OLMA) novel pipeline candidate, OP-1250, for...
Why more women are living with stage 4 breast cancer
The Hill via Yahoo News· 8 months agoWhen Jenny Burkholder, 51, first began feeling chest pain in 2019, she thought it was just the result of a yoga injury. “I went into chaturanga, and I...
Sanofi Ends Development Of Breast Cancer Drug Amcenestrant After Trial Failure
Benzinga via Yahoo Finance· 2 years agoSanofi SA (NASDAQ: SNY) said it would stop further work on breast cancer drug amcenestrant, putting...